前列腺癌根治术后阳性切缘长度与最高Gleason分级对生化复发的预测
回顾性匹配队列研究纳入200例切缘阳性与200例切缘阴性pT2N0/Nx前列腺癌根治术后患者,中位随访64个月,5年无生化复发生存率切缘阴性组90% vs 切缘阳性组70%。多因素分析显示切缘阳性长度>1 mm(HR 2.29)和切缘肿瘤灶最高Gleason分级≥4(HR 6.8)与生化复发相关。
要点
- pT2切缘阳性患者5年无生化复发生存率为70%,切缘阴性组为90%。
- 切缘阳性长度>1 mm较≤1 mm的生化复发风险HR为2.29(95% CI 1.2-4.5)。
- 切缘肿瘤灶最高Gleason分级≥4的生化复发风险HR为6.8(95% CI 1.6-29)。
核心结论
- pT2肿瘤伴切缘阳性长度>1 mm或切缘肿瘤灶Gleason分级≥4的患者生化复发风险升高。
- pT2切缘阳性患者生化复发风险相对较低,辅助放疗可能对该亚组过度治疗。
- 生化复发风险最高的亚组可能受益于更频繁的PSA监测以指导挽救治疗。
研究设计与样本
- 回顾性、匹配的队列研究。
- 纳入200例切缘阳性患者匹配200例切缘阴性患者,均为病理局限(pT2)、淋巴结阴性(pN0/Nx)且未接受辅助治疗。
- 标本由单一病理医生复核。
- 采用Kaplan-Meier法估计无生化复发生存,双侧log-rank检验比较亚组。
- 使用分类与回归树分析(CART)确定切缘阳性长度的最佳截断值。
主要发现
- 中位随访64个月。
- 5年无生化复发生存率:切缘阴性组90%(95% CI 84-97%)vs 切缘阳性组70%(95% CI 63-79%)。
- 任何切缘阳性均与生化复发风险增加相关。
- 多因素分析显示切缘阳性长度>1 mm vs ≤1 mm的HR为2.29(95% CI 1.2-4.5)。
- 多因素分析显示切缘肿瘤灶最高Gleason分级≥4的HR为6.8(95% CI 1.6-29)。
关键数值与推荐
- 切缘阳性长度最佳截断值为1 mm(由CART分析确定)。
- 切缘阳性长度>1 mm vs ≤1 mm:HR 2.29(95% CI 1.2-4.5)。
- 切缘肿瘤灶最高Gleason分级≥4:HR 6.8(95% CI 1.6-29)。
临床怎么用
- 对pT2切缘阳性患者,可依据切缘阳性长度>1 mm和切缘肿瘤灶Gleason分级≥4识别生化复发高危亚组。
- 生化复发风险最高的亚组可能受益于更频繁的PSA监测以指导挽救治疗。
- pT2切缘阳性患者生化复发风险相对较低,辅助放疗可能对该亚组过度治疗。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the pathologic features after radical prostatectomy to determine if the length of positive surgical margin (PSM) and the highest Gleason grade within the tumor at the PSM could risk stratify patients for biochemical recurrence (BCR). METHODS: We performed a retrospective, matched, cohort study to identify patients with pathologically organ-confined (pT2) tumors and negative nodes (pN0/Nx), receiving no adjuvant therapy. Specimens underwent single pathologist review. BCR-free survival was estimated using the Kaplan-Meier method and compared between subgroups using two-sided log-rank test. Using Classification and Regression Tree analysis (CART), we identified an optimal cutoff for the PSM length which differentiated risk for BCR. Cox proportional hazards regression models were fit to assess the association between variables and BCR-free survival. RESULTS: Two-hundred PSM patients were matched to 200 patients with negative surgical margins (NSM). Median follow-up was 64 months. 5 year BCR-free survival was 90% (95% CI 84-97%) in the NSM group and 70% (95% CI 63-79%) in the PSM group. There was an increased risk of BCR with any PSM. Multivariable analysis demonstrated an association with length of PSM ( > 1 mm vs. ≤ 1 mm, HR 2.29; 95% CI 1.2-4.5) and having a highest Gleason grade of the cancer focus at the margin ≥ 4 (HR 6.8; 95% CI 1.6-29). CONCLUSIONS: We demonstrated that patients with pathologic T2 tumors with PSM > 1 mm or a Gleason grade of tumor focus at the margin ≥ 4 are at elevated risk for BCR. However, this study suggests that patients with pT2 tumors with positive surgical margins have a relatively low risk of biochemical recurrence and adjuvant radiation may be over treating this sub population. The subsets at greatest risk for BCR may benefit from more frequent PSA monitoring to direct salvage therapies.
引用
- Chapin BF, Nguyen JN, Achim MF, et al. Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer. Prostate Cancer Prostatic Dis. 2017. PMID: 29230008. doi:10.1038/s41391-017-0019-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。